Recro Pharma Overview

Recro Pharma Cost of Revenue

Cost of Revenue analysis for REPH.

Quarterly Cost of Revenue

$20.02M

↑ 14.82% YoY

As of Dec 31, 2023

Annual Cost of Revenue (TTM)

$76.50M

↑ 14.05% YoY

Trailing 12 months ending Dec 31, 2023

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin